Strengthening medicine availability through enhanced international collaboration: Outcomes from a pilot on global regulatory assessment of manufacturing changes

Medicine shortages continue to represent a critical global health challenge. While causes are multifactorial, issues can be mitigated by measures that increase manufacturing capacity. However, these require regulatory approval, often across multiple jurisdictions, and between-regulator differences in regulatory systems, data requirements and approval timelines can make global approval complex and time consuming. To address this challenge, the International Coalition of Medicines Regulatory Authorities (ICMRA) launched a pilot programme in which five submissions went through collaborative review of the same chemistry, manufacturing and control (CMC) data by up to eight global regulatory authorities, aiming to deliver harmonized outcomes using science and risk-based assessment principles. A standardized 120-day review process was established, enabling near-simultaneous approvals across participating regions. Most (88%) assessment questions were harmonized; alignment reduced the number of questions by 25% compared with independent reviews. These results demonstrate that global regulatory collaboration can significantly accelerate implementation of manufacturing changes, strengthen supply chains and help to mitigate medicine shortages. Efforts are underway to develop this into a sustainable global regulatory approach.

Authors

Institutions

Publication Details

Journal
British Journal of Clinical Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.1002/bcp.70901
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Strengthening medicine availability through enhanced international collaboration: Outcomes from a pilot on global regulatory assessment of manufacturing changes

Evdokia Korakianiti, Theresa Mullin, Yasuhiro Kishioka, Sau Lee et al.
British Journal of Clinical Pharmacology
Pharmaceutical Economics and Policy
article

Strengthening medicine availability through enhanced international collaboration: Outcomes from a pilot on global regulatory assessment of manufacturing changes

Evdokia Korakianiti, Theresa Mullin, Yasuhiro Kishioka, Sau Lee, Seán P. Barry, Evangelos Kotzagiorgis, Susan Polifko
article en

Abstract

Medicine shortages continue to represent a critical global health challenge. While causes are multifactorial, issues can be mitigated by measures that increase manufacturing capacity. However, these require regulatory approval, often across multiple jurisdictions, and between-regulator differences in regulatory systems, data requirements and approval timelines can make global approval complex and time consuming. To address this challenge, the International Coalition of Medicines Regulatory Authorities (ICMRA) launched a pilot programme in which five submissions went through collaborative review of the same chemistry, manufacturing and control (CMC) data by up to eight global regulatory authorities, aiming to deliver harmonized outcomes using science and risk-based assessment principles. A standardized 120-day review process was established, enabling near-simultaneous approvals across participating regions. Most (88%) assessment questions were harmonized; alignment reduced the number of questions by 25% compared with independent reviews. These results demonstrate that global regulatory collaboration can significantly accelerate implementation of manufacturing changes, strengthen supply chains and help to mitigate medicine shortages. Efforts are underway to develop this into a sustainable global regulatory approach.

British Journal of Clinical Pharmacology
European Medicines Agency (NL), Center for Drug Evaluation and Research (US), Health Products Regulatory Authority (IE), Pharmaceuticals and Medical Devices Agency (JP)
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon